Cargando…
Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival
BACKGROUND: The treatment of Colorectal cancer (CRC) is extremely complex and survival rates vary depending on the stage of the disease at the time of diagnosis. Neoadjuvant chemoradiotherapy (NACRT), is the conventional treatment for locally advanced rectal cancer (LARC); however, the resistance to...
Autores principales: | Qin, Changjiang, Li, Ang, Xiao, Yafei, Liu, Wenjing, Zhai, Ertao, Li, Quanying, Jing, Hong, Zhang, Yijie, Zhang, Hui, Ma, Xuhui, Tang, Hongna, Rong, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653697/ https://www.ncbi.nlm.nih.gov/pubmed/37939252 http://dx.doi.org/10.1080/07853890.2023.2278619 |
Ejemplares similares
-
PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells
por: Qin, Changjiang, et al.
Publicado: (2022) -
ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
por: Nicolai, Sara, et al.
Publicado: (2019) -
ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma
por: Zhao, Qingfang, et al.
Publicado: (2023) -
ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma
por: Pieraccioli, Marco, et al.
Publicado: (2018) -
ZNF-281 as the Potential Diagnostic Marker of Oral Squamous Cell Carcinoma
por: Starzyńska, Anna, et al.
Publicado: (2021)